+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Bioinformatics Market to Develop at Robust CAGR of 15.5% Till 2020 with Increasing R&D Initiatives

Posted on Aug 03, 2015

Transparency Market Research has announced the addition of a market study based on the bioinformatics market. According to the report, the global bioinformatics market is estimated to reach US$30.8 billion by 2020. The study states that the bioinformatics market will develop at a robust CAGR of 15.5% from 2014 to 2020. According to the report, the bioinformatics market had reached a value of US$10.0 billion in 2013. The report is titled “Bioinformatics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2014 - 2020”.

 

Browse the full Bioinformatics Market (By Platforms, Tools and Services and By Applications: Preventive Medicine, Molecular Medicine, Gene Therapy Drug Development and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 report at http://www.transparencymarketresearch.com/bioinformatics-market.html

 

During the last ten years, the amplified information technology market growth has in turn driven the bioinformatics market. Bioinformatics helps provide automation of data, accuracy, decreases errors, and reduction in turnaround time (TAT). Bioinformatics has grown due to augmentation of pharmaceutical, bioscience, and life sciences research and development. An upsurge in government support has fueled research and development activities that have resulted in amplified acceptance of biopharmatics in practice. 

 

However, the lack of skilled personnel and lack of uniform formats for bioinformatics tools and platforms has restrained the growth of the bioinformatics market. The rising possibility of web-based services and crucial collaborations with wet laboratories are expected to provide new opportunities in the bioinformatics market. Bioinformatics helps data management, retrieval, integration from healthcare research, and processing of data through automation. Bioinformatics is extensively used in processing, converting, and recording data obtained from research connected to biotechnology, pharmaceutical, agriculture, and life science to digitalized data that can be used further. 

                              

The global bioinformatics market segmentation can be broken down into services, platforms, and tools. On the basis of platforms, the bioinformatics market is segregated into sequence analysis platforms, sequence manipulation platforms, sequence alignment platforms, and structural analysis platforms. Among these segments, the sequence alignment platform contributed the largest share of over 30% in 2013. This segment had a sizeable share in the market owing to reduced time for processing data, identification of sequence similarity, motif finding, and phylogenetic analysis.On the basis of applications, the global bioinformatics market is divided into gene therapy, molecular medicine, drug development, preventive medicine, and others. The molecular medicine application segment is foremost due to major companies financing research related to pharmacoprotemics, pharmacogenomics, and metabolomics. Additionally, the heightened investments in drug development and discovery have propelled the drug development application segment, and this application is expected to increase in demand over the forecast period. 

 

The report describes in detail the bioinformatics market segmentation based on geographical regions. These regions are categorized into North America, Europe, Asia Pacific, and Rest of World (RoW). North America had the largest share of 35% in bioinformatics in 2013 due to the availability of skilled personnel, advanced technology, and high implementation of bioinformatics in the region. According to the report, the Asia Pacific bioinformatics market is foreseen to expand at a strong CAGR due to the fast expansion of the bioinformatics industry in the region and government investments. The key market players contributing to the bioinformatics industry include GenoLogics Life Sciences Software, Accelrys, Inc., Affymetrix, Inc., and Agilent Technologies Inc.

 

Key segments of the Bioinformatics market

 

Bioinformatics Market, by Platforms, Tools, and Services

  • Platforms

    • Sequence Manipulation Platforms
    • Sequence Alignment Platforms
    • Structural Analysis Platforms
    • Sequence Analysis Platforms
  • Tools

    • General Knowledge Management Tools
    • Specialized Knowledge Management Tools
  • Services

    • Data analysis
    • Sequencing services
    • Database & management
    • Other services

Bioinformatics Market, by Applications

  • Preventive medicine
  • Molecular medicine
  • Gene therapy
  • Drug development
  • Others

Bioinformatics Market, by Geography

  • North America
  • Europe 
  • Asia-Pacific
  • Rest of the World 

Browse : Our new press releases http://www.transparencymarketresearch.com/pressrelease/bioinformatics-industry.htm

About Us

 

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. 

 

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

 

Contact

Mr.Sudip S
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

Back To Top